Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Process for manufacturing pharmaceutical composition comprises of Mycobacterium w in the treatment of asthma (obstructive lung disease)

Process for manufacturing pharmaceutical composition comprises of Mycobacterium w in the treatment of asthma (obstructive lung disease)

US Patent 8153102 · Granted Apr 10, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic cancer vaccine2022
Synthesis of novel intermediate(s) for preparing rivastigmine2021
Synthesis of novel intermediate(s) for preparing rivastigmine2021
Therapeutic cancer vaccine2019
Pharmaceutical composition of killed cells with substantially retained immunogen2017
Pharmaceutical composition of killed cells with substantially retained immunogen2017
Stable pharmaceutical composition for atherosclerosis2017
Stable pharmaceutical composition for atherosclerosis2017
Cancer antigen2017
Indole 3-carbinol derivatives2017
Pharmaceutical compositions of curcumin2016
Method of treating desmocollin-3 expressing cancer with Mycobacterium w2016